{"id":"https://openalex.org/W2062630004","doi":"https://doi.org/10.1097/00008571-200411000-00004","title":"Contribution of common polymorphisms in reduced folate carrier and ??-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis","display_name":"Contribution of common polymorphisms in reduced folate carrier and ??-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis","publication_year":2004,"publication_date":"2004-11-01","ids":{"openalex":"https://openalex.org/W2062630004","doi":"https://doi.org/10.1097/00008571-200411000-00004","mag":"2062630004","pmid":"https://pubmed.ncbi.nlm.nih.gov/15564880"},"language":"en","primary_location":{"id":"doi:10.1097/00008571-200411000-00004","doi":"https://doi.org/10.1097/00008571-200411000-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008571-200411000-00004","pdf_url":null,"source":{"id":"https://openalex.org/S196130971","display_name":"Pharmacogenetics","issn_l":"0960-314X","issn":["0960-314X","1473-561X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073369495","display_name":"Thierry Dervieux","orcid":"https://orcid.org/0000-0002-3799-4438","observed_orcids":["https://orcid.org/0000-0002-3799-4438"]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thierry Dervieux","raw_affiliation_strings":["Prometheus Laboratories, San Diego, California, USA","Prometheus Laboratories, San Diego, California,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Laboratories, San Diego, California, USA","institution_ids":[]},{"raw_affiliation_string":"Prometheus Laboratories, San Diego, California,","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014147030","display_name":"Joel M. Kremer","orcid":"https://orcid.org/0000-0001-6674-9901","observed_orcids":["https://orcid.org/0000-0001-6674-9901"]},"institutions":[{"id":"https://openalex.org/I4210159453","display_name":"Center for Rheumatology","ror":"https://ror.org/04rtaxr13","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210159453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel Kremer","raw_affiliation_strings":["The Centre for Rheumatology, Albany, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Centre for Rheumatology, Albany, New York","institution_ids":["https://openalex.org/I4210159453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021773294","display_name":"Diana Orentas Lein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diana Orentas Lein","raw_affiliation_strings":["Prometheus Laboratories, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Laboratories, San Diego, California","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert Capps","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Capps","raw_affiliation_strings":["Rheumatology Consultant, Knoxville, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology Consultant, Knoxville, Tennessee","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108821967","display_name":"Robert Barham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Barham","raw_affiliation_strings":["Prometheus Laboratories, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Laboratories, San Diego, California","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039850816","display_name":"Gary E. Meyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Meyer","raw_affiliation_strings":["Prometheus Laboratories, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Laboratories, San Diego, California","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113676309","display_name":"Katie Smith","orcid":"https://orcid.org/0009-0008-7799-3676","observed_orcids":["https://orcid.org/0009-0008-7799-3676"]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katie Smith","raw_affiliation_strings":["Prometheus Laboratories, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Laboratories, San Diego, California","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110203793","display_name":"Jacques R. Caldwell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124370","display_name":"Radiant Research (United States)","ror":"https://ror.org/03fz1e596","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacques Caldwell","raw_affiliation_strings":["Radiant Research, Daytona Beach, Florida and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiant Research, Daytona Beach, Florida and","institution_ids":["https://openalex.org/I4210124370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059206584","display_name":"Daniel E. Furst","orcid":"https://orcid.org/0000-0001-7857-2373","observed_orcids":["https://orcid.org/0000-0001-7857-2373","https://orcid.org/0000-0002-4018-7629"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel E Furst","raw_affiliation_strings":["UCLA Geffen School of Medecine, Los Angeles, California, USA","and requests for reprints to Daniel E. Furst, Carl M. Pearson Professor of Rheumatology, University of California at Los Angeles, 1000 Veteran Avenue Room 32\u201359, Los Angeles, CA 90025-1670, USA. Tel: +1310 7949504; fax: +1310 2068476; e-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA Geffen School of Medecine, Los Angeles, California, USA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"and requests for reprints to Daniel E. Furst, Carl M. Pearson Professor of Rheumatology, University of California at Los Angeles, 1000 Veteran Avenue Room 32\u201359, Los Angeles, CA 90025-1670, USA. Tel: +1310 7949504; fax: +1310 2068476; e-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5059206584"],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":null,"apc_paid":null,"fwci":5.1921,"has_fulltext":false,"cited_by_count":160,"citation_normalized_percentile":{"value":0.95326046,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"14","issue":"11","first_page":"733","last_page":"739"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9550999999046326,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9550999999046326,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.014499999582767487,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10499","display_name":"Folate and B Vitamins Research","score":0.013399999588727951,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methotrexate-polyglutamates","display_name":"methotrexate polyglutamates","score":0.925000011920929},{"id":"https://openalex.org/keywords/reduced-folate-carrier","display_name":"reduced folate carrier","score":0.9039999842643738},{"id":"https://openalex.org/keywords/slc19a1","display_name":"SLC19A1","score":0.9039999842643738},{"id":"https://openalex.org/keywords/gamma-glutamyl-hydrolase","display_name":"gamma-glutamyl hydrolase","score":0.9240000247955322},{"id":"https://openalex.org/keywords/methotrexate-pharmacokinetics","display_name":"methotrexate pharmacokinetics","score":0.7110000252723694},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.8159999847412109},{"id":"https://openalex.org/keywords/genetic-polymorphism","display_name":"genetic polymorphism","score":0.6449999809265137},{"id":"https://openalex.org/keywords/drug-response-prediction","display_name":"drug response prediction","score":0.4359999895095825}],"concepts":[{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.9107656478881836},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.8359808921813965},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.6177455186843872},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5938853025436401},{"id":"https://openalex.org/C43563269","wikidata":"https://www.wikidata.org/wiki/Q424709","display_name":"Methylenetetrahydrofolate reductase","level":4,"score":0.5454840660095215},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38677769899368286},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37646597623825073},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37281379103660583},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3209761381149292},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.29419755935668945},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.26349982619285583},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2212696671485901},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1693018078804016}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001483","descriptor_name":"Base Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011099","descriptor_name":"Polyglutamic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D011099","descriptor_name":"Polyglutamic Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011623","descriptor_name":"gamma-Glutamyl Hydrolase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D017931","descriptor_name":"DNA Primers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D026901","descriptor_name":"Membrane Transport Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D058978","descriptor_name":"Reduced Folate Carrier Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00008571-200411000-00004","doi":"https://doi.org/10.1097/00008571-200411000-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008571-200411000-00004","pdf_url":null,"source":{"id":"https://openalex.org/S196130971","display_name":"Pharmacogenetics","issn_l":"0960-314X","issn":["0960-314X","1473-561X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"journal-article"},{"id":"pmid:15564880","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15564880","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W29771769","https://openalex.org/W161304231","https://openalex.org/W1489298252","https://openalex.org/W1548013608","https://openalex.org/W1594621311","https://openalex.org/W1596051841","https://openalex.org/W1755860332","https://openalex.org/W1982767795","https://openalex.org/W1983779362","https://openalex.org/W2010650782","https://openalex.org/W2019995269","https://openalex.org/W2043804660","https://openalex.org/W2047861739","https://openalex.org/W2053006426","https://openalex.org/W2053867192","https://openalex.org/W2058471639","https://openalex.org/W2069009549","https://openalex.org/W2070009272","https://openalex.org/W2070822335","https://openalex.org/W2071035298","https://openalex.org/W2075437346","https://openalex.org/W2078993588","https://openalex.org/W2083020021","https://openalex.org/W2094803435","https://openalex.org/W2101259585","https://openalex.org/W2115030795","https://openalex.org/W2124525707","https://openalex.org/W2129800472","https://openalex.org/W2136430968","https://openalex.org/W2139540775","https://openalex.org/W2140359066","https://openalex.org/W2140846610","https://openalex.org/W2143674871","https://openalex.org/W2145956223","https://openalex.org/W2148708125","https://openalex.org/W2151884828","https://openalex.org/W2157940881","https://openalex.org/W2161501094","https://openalex.org/W2161587142","https://openalex.org/W2161980441","https://openalex.org/W2331320446","https://openalex.org/W2342829092","https://openalex.org/W2410125504","https://openalex.org/W2603259205","https://openalex.org/W4285719527","https://openalex.org/W4406311718"],"related_works":["https://openalex.org/W2537850200","https://openalex.org/W1983779362","https://openalex.org/W2908964971","https://openalex.org/W2883142851","https://openalex.org/W2063415680","https://openalex.org/W7123844458","https://openalex.org/W4386110744","https://openalex.org/W2043352630","https://openalex.org/W2102076856","https://openalex.org/W2169431625"],"abstract_inverted_index":{"We":[0],"investigated":[1],"whether":[2],"polymorphisms":[3,248],"in":[4,20,38,76,83,249],"reduced":[5],"folate":[6],"carrier":[7],"(SLC19A1":[8],"G80A)":[9],"and":[10,54,78,96,155,160,251],"gamma-glutamyl-hydrolase":[11],"(GGH-401C/T)":[12],"are":[13],"predictive":[14],"of":[15,48,65,131,151,202,255],"methotrexate":[16,29],"polyglutamate":[17],"(MTXPG)":[18],"levels":[19,60,163,222],"patients":[21,32,109,133,141],"with":[22,26,34,172,210,230],"rheumatoid":[23],"arthritis":[24],"treated":[25,33],"weekly":[27],"low-dose":[28],"(MTX).":[30],"Adult":[31],"MTX":[35,111,147],"were":[36,67,85,99,176,215],"enrolled":[37],"a":[39,79],"multicentred":[40],"study.":[41],"Blood":[42],"was":[43,52,122],"drawn":[44],"at":[45],"the":[46,49,63,135,143,152,173,195,203,211,224,231],"time":[47],"visit,":[50],"DNA":[51],"extracted":[53],"red":[55],"blood":[56],"cell":[57],"(RBC)":[58],"MTXPG":[59],"(up":[61],"to":[62,101,191,199,219,228],"penta-order":[64],"glutamation)":[66],"measured":[68,86],"by":[69,87],"high-performance":[70],"liquid":[71],"chromatography-fluorometry.":[72],"A":[73,129],"G80A":[74],"polymorphism":[75,82],"SLC19A1":[77,136,153,212,232,250],"-401C/T":[80],"promoter":[81],"GGH":[84,252],"polymerase":[88],"chain":[89],"reaction-restriction":[90],"fragment":[91],"length":[92],"polymorphism.":[93],"Multivariate":[94],"linear":[95],"logistic":[97],"regressions":[98],"used":[100],"predict":[102],"long-chain":[103,120],"RBC":[104,119],"MTXPG3-5.":[105],"In":[106],"226":[107],"adult":[108],"receiving":[110],"(median":[112],"15":[113],"mg":[114],"range:":[115],"5-25":[116],"mg)":[117],"median":[118,197,226],"MTXPG3-5":[121,162,193,221],"56":[123],"nmol/l":[124],"(range":[125],"<":[126,169],"5-224":[127],"nmol/l).":[128],"total":[130],"35":[132],"carried":[134,142],"80AA":[137,154,213],"genotype":[138,175,214,236],"whereas":[139],"36":[140],"GGH-401TT":[144,156,174],"genotype.":[145,207],"Weekly":[146],"dose,":[148],"age,":[149],"presence":[150],"genotypes":[157],"predicted":[158],"independently":[159],"significantly":[161],"(global":[164],"r":[165],"=":[166,187,242],"0.38;":[167],"P":[168,186,241],"0.0001).":[170],"Patients":[171],"4.8-fold":[177],"[odds":[178],"ratio":[179],"(OR)":[180],"95%":[181,239],"confidence":[182],"interval":[183],"(CI)":[184],"1.8-13.0;":[185],"0.002]":[188],"more":[189,217],"likely":[190,218],"have":[192,220],"below":[194],"group":[196,225],"compared":[198,227],"patient":[200],"carriers":[201],"GGH-401CC":[204],"or":[205,234],"CT":[206],"Conversely,":[208],"those":[209,229],"3.4-fold":[216],"above":[223],"80GG":[233],"80GA":[235],"(OR":[237],"CI":[238],"1.4-8.4;":[240],"0.007).":[243],"These":[244],"data":[245],"demonstrate":[246],"that":[247],"affect":[253],"polyglutamation":[254],"MTX.":[256]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":16},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}